Outcomes
exacerbations, COPD
ADVERSE EVENTS, COPD, SECONDARY
The primary outcome was the number of participant‐reported severe exacerbations requiring hospital admission during the 6‐month treatment period. In addition to exacerbation data, the following secondary outcomes were collected: dose adjustment rate of inhaled drugs containing glucocorticoid; adverse events; clinical symptoms; COPD‐related health status (CAT scale, ≤5 being the norm for healthy nonsmokers and >30 indicating a very high effect of COPD on quality of life)